Red Light for Venous Leg Ulcers: What the 2026 Evidence Shows

Venous leg ulcers need a different answer from diabetic ulcers

A venous leg ulcer is usually driven by chronic venous hypertension and impaired return of blood from the lower leg. That is a different disease process from a diabetic neuropathic ulcer, pressure injury or surgical wound.

This distinction matters because PBM evidence that looks promising in one wound class cannot be copied into another.

What does the newest systematic review show?

A 2026 systematic review and meta-analysis identified 11 randomized trials, with four studies contributing to pooled ulcer-area analysis. PBM did not significantly reduce ulcer area compared with controls. Heterogeneity was very high and all included studies had some or high risk-of-bias concerns.

That makes the current conclusion unusually clear: PBM remains investigational for venous leg ulcer healing, and the evidence does not support presenting it as an established treatment.

Why compression matters

For an appropriately assessed venous ulcer, compression therapy addresses the underlying venous hypertension. Wound dressings, mobility, edema management and vascular evaluation also matter.

A light device cannot substitute for compression when compression is clinically appropriate, and compression should not be started blindly if significant arterial disease has not been excluded.

Are there promising wavelengths?

Trials have used several red and infrared protocols, but the 2026 review found substantial methodological heterogeneity and concluded that treatment standards are still missing.

That means it would be misleading to promote a specific wavelength such as 660 or 850 nm as the “best” wavelength for venous ulcers.

When a leg ulcer needs prompt assessment

Seek professional care for a persistent lower-leg ulcer, especially with increasing pain, spreading redness, fever, foul drainage, black tissue, severe swelling, rapidly changing size or signs of poor circulation.

Leg ulcers can also be arterial, mixed arterial/venous, neuropathic, inflammatory or malignant. Correct diagnosis comes before adjunctive device selection.

What this means for home red-light devices

A consumer panel should not be treated as a substitute for a wound-clinic protocol. The strongest current evidence does not demonstrate a significant pooled healing advantage, and unsupervised use risks delaying care that addresses the actual vascular cause.

For other wound categories, see Diabetic Foot Ulcers, Pressure Injuries, Burn Wounds and Surgical Wounds. Return to Red Light Therapy by Condition.